Milan R. Uskoković

12.0k total citations
268 papers, 9.3k citations indexed

About

Milan R. Uskoković is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Milan R. Uskoković has authored 268 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Pathology and Forensic Medicine, 101 papers in Molecular Biology and 75 papers in Organic Chemistry. Recurrent topics in Milan R. Uskoković's work include Vitamin D Research Studies (103 papers), Estrogen and related hormone effects (66 papers) and Biotin and Related Studies (36 papers). Milan R. Uskoković is often cited by papers focused on Vitamin D Research Studies (103 papers), Estrogen and related hormone effects (66 papers) and Biotin and Related Studies (36 papers). Milan R. Uskoković collaborates with scholars based in United States, Switzerland and Japan. Milan R. Uskoković's co-authors include Peter M. Wovkulich, Eǹrico G. Baggiolini, Luciano Adorini, John J. Partridge, H. Phillip Koeffler, Nadia Giarratana, Hubert Maehr, Guilin Qiao, Juan Kong and Yan Chun Li and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Milan R. Uskoković

267 papers receiving 8.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Milan R. Uskoković United States	50	4.0k	2.9k	2.4k	2.1k	1.1k	268	9.3k
Sachiko Yamada Japan	36	1.9k 0.5×	1.1k 0.4×	957 0.4×	889 0.4×	684 0.6×	225	4.8k
Marion Kirk United States	42	1.4k 0.4×	2.5k 0.9×	614 0.3×	558 0.3×	398 0.4×	82	6.8k
Ronald A. Lubet United States	57	1.1k 0.3×	5.4k 1.9×	771 0.3×	2.2k 1.1×	3.0k 2.7×	344	12.7k
Shantu Amin United States	60	863 0.2×	9.0k 3.1×	2.2k 0.9×	808 0.4×	2.3k 2.0×	437	15.4k
Nanjoo Suh United States	53	739 0.2×	5.0k 1.7×	984 0.4×	893 0.4×	1.3k 1.1×	108	7.9k
Matthew M. Ames United States	51	637 0.2×	4.0k 1.4×	534 0.2×	1.3k 0.6×	2.7k 2.4×	239	9.3k
Levy Kopelovich United States	50	1.2k 0.3×	4.8k 1.7×	374 0.2×	1.1k 0.5×	2.5k 2.2×	214	9.2k
James T. Dalton United States	55	481 0.1×	3.4k 1.2×	1.6k 0.7×	1.9k 0.9×	1.4k 1.2×	203	9.6k
A. M. Lawson United Kingdom	37	966 0.2×	1.9k 0.7×	446 0.2×	388 0.2×	653 0.6×	97	4.4k
Joachim G. Liehr United States	40	576 0.1×	3.3k 1.1×	738 0.3×	3.1k 1.5×	1.1k 1.0×	143	7.2k

Countries citing papers authored by Milan R. Uskoković

Since Specialization

Citations

This map shows the geographic impact of Milan R. Uskoković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milan R. Uskoković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milan R. Uskoković more than expected).

Fields of papers citing papers by Milan R. Uskoković

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milan R. Uskoković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milan R. Uskoković. The network helps show where Milan R. Uskoković may publish in the future.

Co-authorship network of co-authors of Milan R. Uskoković

This figure shows the co-authorship network connecting the top 25 collaborators of Milan R. Uskoković. A scholar is included among the top collaborators of Milan R. Uskoković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milan R. Uskoković. Milan R. Uskoković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wahler, J., Jae Young So, Fang Liu, et al.. (2014). Inhibition of the Transition of Ductal Carcinoma In Situ to Invasive Ductal Carcinoma by a Gemini Vitamin D Analog. Cancer Prevention Research. 7(6). 617–626. 14 indexed citations

Annalora, Andrew J., Erika LaPorta, JoEllen Welsh, et al.. (2014). Potent Antiproliferative Effects of 25‐Hydroxy‐16‐ene‐23‐yne‐vitamin D₃ That Resists the Catalytic Activity of Both CYP27B1 and CYP24A1. Journal of Cellular Biochemistry. 115(8). 1392–1402. 11 indexed citations

So, Jae Young, J. Wahler, Amanda K. Smolarek, et al.. (2013). Oral Administration of a Gemini Vitamin D Analog, a Synthetic Triterpenoid and the Combination Prevents Mammary Tumorigenesis Driven by ErbB2 Overexpression. Cancer Prevention Research. 6(9). 959–970. 22 indexed citations

McNally, Paul, Gudmundur Bergsson, Clifford C. Taggart, et al.. (2011). Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis. Journal of Cystic Fibrosis. 10(6). 428–434. 48 indexed citations

Lee, Hong Jin, Andrew DeCastro, Amanda K. Smolarek, et al.. (2010). Gemini vitamin D analog suppresses ErbB2-positive mammary tumor growth via inhibition of ErbB2/AKT/ERK signaling. The Journal of Steroid Biochemistry and Molecular Biology. 121(1-2). 408–412. 28 indexed citations

So, Jae Young, Hong Jin Lee, Amanda K. Smolarek, et al.. (2010). A Novel Gemini Vitamin D Analog Represses the Expression of a Stem Cell Marker CD44 in Breast Cancer. Molecular Pharmacology. 79(3). 360–367. 69 indexed citations

Lee, Hong Jin, Hao Liu, Catherine Goodman, et al.. (2006). Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer. Biochemical Pharmacology. 72(3). 332–343. 55 indexed citations

Bula, Craig M., June E. Bishop, Luciano Adorini, et al.. (2004). Characterization of five 19-nor-analogs of 1α,25(OH)2-Vitamin D3 with 20-cyclopropyl-modified side-chains: implications for ligand binding and calcemic properties. The Journal of Steroid Biochemistry and Molecular Biology. 89-90(1-5). 99–106. 7 indexed citations

Rao, D.Sunita, Dhruv R Balkundi, Milan R. Uskoković, et al.. (2001). Double bond in the side chain of 1α,25-dihydroxy-22-ene-vitamin D3 is reduced during its metabolism: studies in chronic myeloid leukemia (RWLeu-4) cells and rat kidney. The Journal of Steroid Biochemistry and Molecular Biology. 78(2). 167–176. 4 indexed citations

10.

Moore, J., et al.. (2001). Synergistic growth inhibition of prostate cancer cells by 1α,25 Dihydroxyvitamin D3 and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A. Oncogene. 20(15). 1860–1872. 91 indexed citations

11.

Bansal, Devi Dayal, et al.. (2000). Induction of tissue plasminogen activator secretion from rat heart microvascular cells by fM 1,25(OH)₂D₃. American Journal of Physiology-Endocrinology and Metabolism. 278(2). E293–E301. 11 indexed citations

12.

Kabat, Marek M., Sandra E. Guggino, B. M. HENNESSY, et al.. (1998). Total synthesis of 25-Hydroxy-16,23E-diene Vitamin D3 and 1α,25-Dihydroxy-16,23E-diene Vitamin D3: separation of genomic and nongenomic vitamin D Activities. Bioorganic & Medicinal Chemistry. 6(11). 2051–2059. 11 indexed citations

13.

Vos, Sven de, Stuart Holden, David Heber, et al.. (1997). Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines. The Prostate. 31(2). 77–83. 35 indexed citations

14.

Cheskis, Boris J., Bryan D. Lemon, Milan R. Uskoković, Peter T. Lomedico, & Leonard P. Freedman. (1995). Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25-dihydroxyvitamin D3.. Molecular Endocrinology. 9(12). 1814–1824. 43 indexed citations

15.

Wovkulich, Peter M., K. Shankaran, Katarzyna Kiegiel, & Milan R. Uskoković. (1993). Total synthesis of 1233A. The Journal of Organic Chemistry. 58(4). 832–839. 141 indexed citations

16.

Wovkulich, Peter M., et al.. (1984). Stereoselective total synthesis of 1α,25S,26-trihydroxycholecalciferol. Tetrahedron. 40(12). 2283–2296. 64 indexed citations

17.

Wovkulich, Peter M., Eǹrico G. Baggiolini, B. M. HENNESSY, et al.. (1984). ChemInform Abstract: TOTAL SYNTHESIS OF 1α,25(R)‐DIHYDROXY VITAMIN D3 26, 23(S)‐LACTONE (CALCITRIOL LACTONE), A NATURAL METABOLITE OF VITAMIN D3. Chemischer Informationsdienst. 15(18). 2 indexed citations

18.

BROSSI, A., Milan R. Uskoković, J. Gutzwiller, Antoniana U. Krettli, & Z. Brener. (1971). Antimalarial activity of natural, racemic and unnatural dihydroquinine, dihydroquinidine and their various racemic analogs in mice infected withPlasmodium berghei. Cellular and Molecular Life Sciences. 27(9). 1100–1101. 13 indexed citations

19.

Williams, Thomas H., Ross G. Pitcher, P. Bommer, J. Gutzwiller, & Milan R. Uskoković. (1969). Diastereomeric solute-solute interactions of enantiomers in achiral solvents. Nonequivalence of the nuclear magnetic resonance spectra of racemic and optically active dihydroquinine. Journal of the American Chemical Society. 91(7). 1871–1872. 102 indexed citations

20.

Paul, Iain C., et al.. (1969). Structures of two diastereoisomeric sulfoxides. 3,5-Dihydro-3-methyl-4,1-benzothiazepin-2(1H)-one 4-oxides. The Journal of Organic Chemistry. 34(2). 365–371. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact